Breast cancer-specific mortality in early breast cancer as defined by high-risk clinical and pathologic characteristics | PLOS ONE
![Survival outcomes for dose‐dense paclitaxel plus carboplatin neoadjuvant vs standard adjuvant chemotherapy in stage II to III triple‐negative breast cancer: A prospective cohort study with propensity‐matched analysis - Xiu - 2022 - Survival outcomes for dose‐dense paclitaxel plus carboplatin neoadjuvant vs standard adjuvant chemotherapy in stage II to III triple‐negative breast cancer: A prospective cohort study with propensity‐matched analysis - Xiu - 2022 -](https://onlinelibrary.wiley.com/cms/asset/57bcd5d6-acc1-43b5-a184-333567c07174/ijc34022-toc-0001-m.jpg)
Survival outcomes for dose‐dense paclitaxel plus carboplatin neoadjuvant vs standard adjuvant chemotherapy in stage II to III triple‐negative breast cancer: A prospective cohort study with propensity‐matched analysis - Xiu - 2022 -
![Frontiers | Triple-Negative Breast Cancer: A Brief Review About Epidemiology, Risk Factors, Signaling Pathways, Treatment and Role of Artificial Intelligence Frontiers | Triple-Negative Breast Cancer: A Brief Review About Epidemiology, Risk Factors, Signaling Pathways, Treatment and Role of Artificial Intelligence](https://www.frontiersin.org/files/Articles/836417/fmolb-09-836417-HTML/image_m/fmolb-09-836417-g002.jpg)
Frontiers | Triple-Negative Breast Cancer: A Brief Review About Epidemiology, Risk Factors, Signaling Pathways, Treatment and Role of Artificial Intelligence
![Integrating Immunotherapy Into the Treatment Landscape for Patients With Triple-Negative Breast Cancer | American Society of Clinical Oncology Educational Book Integrating Immunotherapy Into the Treatment Landscape for Patients With Triple-Negative Breast Cancer | American Society of Clinical Oncology Educational Book](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/edbk/2022/edbk.2022.42.issue-1/edbk_351186/20220707/images/large/edbk_351186-table1.jpeg)
Integrating Immunotherapy Into the Treatment Landscape for Patients With Triple-Negative Breast Cancer | American Society of Clinical Oncology Educational Book
![Biomimetic black phosphorus quantum dots-based photothermal therapy combined with anti-PD-L1 treatment inhibits recurrence and metastasis in triple-negative breast cancer | Journal of Nanobiotechnology | Full Text Biomimetic black phosphorus quantum dots-based photothermal therapy combined with anti-PD-L1 treatment inhibits recurrence and metastasis in triple-negative breast cancer | Journal of Nanobiotechnology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12951-021-00932-2/MediaObjects/12951_2021_932_Figa_HTML.png)
Biomimetic black phosphorus quantum dots-based photothermal therapy combined with anti-PD-L1 treatment inhibits recurrence and metastasis in triple-negative breast cancer | Journal of Nanobiotechnology | Full Text
![Frontiers | A Risk Stratification Model for Predicting Overall Survival and Surgical Benefit in Triple-Negative Breast Cancer Patients With de novo Distant Metastasis Frontiers | A Risk Stratification Model for Predicting Overall Survival and Surgical Benefit in Triple-Negative Breast Cancer Patients With de novo Distant Metastasis](https://www.frontiersin.org/files/Articles/512973/fonc-10-00014-HTML/image_m/fonc-10-00014-g001.jpg)
Frontiers | A Risk Stratification Model for Predicting Overall Survival and Surgical Benefit in Triple-Negative Breast Cancer Patients With de novo Distant Metastasis
![Triple‑negative breast cancer: A run‑through of features, classification and current therapies (Review) Triple‑negative breast cancer: A run‑through of features, classification and current therapies (Review)](https://www.spandidos-publications.com/article_images/ol/22/1/ol-22-01-12773-g02.jpg)
Triple‑negative breast cancer: A run‑through of features, classification and current therapies (Review)
![Clinical significance of CD73 in triple-negative breast cancer: multiplex analysis of a phase III clinical trial - Annals of Oncology Clinical significance of CD73 in triple-negative breast cancer: multiplex analysis of a phase III clinical trial - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/f7f74744-015a-448d-8dbe-9cbdbbbc8c8b/gr1_lrg.jpg)
Clinical significance of CD73 in triple-negative breast cancer: multiplex analysis of a phase III clinical trial - Annals of Oncology
![Treatment patterns, risk for hospitalization and mortality in older patients with triple negative breast cancer - Journal of Geriatric Oncology Treatment patterns, risk for hospitalization and mortality in older patients with triple negative breast cancer - Journal of Geriatric Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/550b1d57-7e0e-4329-9c1c-26c3dee6f2d9/gr1_lrg.jpg)
Treatment patterns, risk for hospitalization and mortality in older patients with triple negative breast cancer - Journal of Geriatric Oncology
![Risk of recurrence in different sites in triple-negative breast cancer... | Download Scientific Diagram Risk of recurrence in different sites in triple-negative breast cancer... | Download Scientific Diagram](https://www.researchgate.net/publication/234070517/figure/fig1/AS:203314101788672@1425485267846/Risk-of-recurrence-in-different-sites-in-triple-negative-breast-cancer-patients.png)
Risk of recurrence in different sites in triple-negative breast cancer... | Download Scientific Diagram
![Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies - ScienceDirect Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1535610819300960-fx1.jpg)
Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies - ScienceDirect
![Integrated analysis reveals the molecular features of fibrosis in triple-negative breast cancer: Molecular Therapy - Oncolytics Integrated analysis reveals the molecular features of fibrosis in triple-negative breast cancer: Molecular Therapy - Oncolytics](https://www.cell.com/cms/attachment/26e4fb1e-70db-41f7-a4ad-9e0f49599a1a/fx1_lrg.jpg)
Integrated analysis reveals the molecular features of fibrosis in triple-negative breast cancer: Molecular Therapy - Oncolytics
Aurora-A Identifies Early Recurrence and Poor Prognosis and Promises a Potential Therapeutic Target in Triple Negative Breast Cancer | PLOS ONE
![JCM | Free Full-Text | Triple Negative Breast Cancer: An Analysis of the Subtypes and the Effects of Menopausal Status on Invasive Breast Cancer | HTML JCM | Free Full-Text | Triple Negative Breast Cancer: An Analysis of the Subtypes and the Effects of Menopausal Status on Invasive Breast Cancer | HTML](https://www.mdpi.com/jcm/jcm-11-02331/article_deploy/html/images/jcm-11-02331-g002b.png)
JCM | Free Full-Text | Triple Negative Breast Cancer: An Analysis of the Subtypes and the Effects of Menopausal Status on Invasive Breast Cancer | HTML
![Prognosis of triple-negative breast cancer associated with pregnancy: A propensity score-matched analysis from the French CALG (Cancer Associé à la Grossesse) network - The Breast Prognosis of triple-negative breast cancer associated with pregnancy: A propensity score-matched analysis from the French CALG (Cancer Associé à la Grossesse) network - The Breast](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/72258ffb-1269-4af6-8710-65761413ec2b/gr1_lrg.jpg)
Prognosis of triple-negative breast cancer associated with pregnancy: A propensity score-matched analysis from the French CALG (Cancer Associé à la Grossesse) network - The Breast
![Adjuvant capecitabine-containing chemotherapy benefit and homologous recombination deficiency in early-stage triple-negative breast cancer patients | British Journal of Cancer Adjuvant capecitabine-containing chemotherapy benefit and homologous recombination deficiency in early-stage triple-negative breast cancer patients | British Journal of Cancer](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41416-022-01711-y/MediaObjects/41416_2022_1711_Fig1_HTML.png)
Adjuvant capecitabine-containing chemotherapy benefit and homologous recombination deficiency in early-stage triple-negative breast cancer patients | British Journal of Cancer
![A comparison between young and old patients with triple-negative breast cancer: biology, survival and metastatic patterns | SpringerLink A comparison between young and old patients with triple-negative breast cancer: biology, survival and metastatic patterns | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10549-020-05727-x/MediaObjects/10549_2020_5727_Fig2_HTML.png)
A comparison between young and old patients with triple-negative breast cancer: biology, survival and metastatic patterns | SpringerLink
![Current Oncology | Free Full-Text | Current and New Novel Combination Treatments for Metastatic Triple-Negative Breast Cancer | HTML Current Oncology | Free Full-Text | Current and New Novel Combination Treatments for Metastatic Triple-Negative Breast Cancer | HTML](https://www.mdpi.com/curroncol/curroncol-29-00377/article_deploy/html/images/curroncol-29-00377-g001.png)